查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594991

全球商店(OTC) 测试市场

Over The Counter (OTC) Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球商店(OTC) 检测市场预计将达到 436 亿美元

全球商店(OTC) 检测市场预计 2023 年为 233 亿美元，预计到 2030 年将达到 436 亿美元，2023-2030 年分析期间复合年增长率为 9.3%。血糖监测测试是本报告分析的细分市场之一，预计复合年增长率为 8.2%，到分析期结束时将达到 117 亿美元。在分析期间，妊娠和不孕症检测行业的复合年增长率预计为 9.5%。

美国市场预计将成长63亿美元，中国复合年增长率为8.8%

预计 2023 年美国商店(OTC) 检测市场规模将达 63 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达到68亿美元，2023年至2030年的分析期间复合年增长率为8.8%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 7.8% 和 7.8%。在欧洲，德国的复合年增长率预计约为 6.6%。

全球非处方药物 (OTC) 测试市场 - 主要趋势和驱动因素总结

为什么商店测试对于可近的医疗保健至关重要？

非处方 (OTC) 检测彻底改变了医疗保健，让个人可以直接在家中方便地进行健康检测。 OTC 测试可以监测各种健康指标，从血糖值和胆固醇水平到怀孕、不孕和感染疾病，无需医生就诊或处方笺。随着医疗保健转向更加以患者为中心和更容易获得的护理，OTC 测试已成为寻求主动健康管理的个人的重要工具。方便的 OTC 检测消除了与传统实验室检测相关的障碍，例如时间、成本和可近性问题，使医疗保健更加全面。

非处方药检测对糖尿病等慢性病的管理影响特别大，持续监测对于有效照护至关重要。血糖值仪是最广泛使用的非处方药测试之一，它可以让糖尿病患者追踪他们的日常血糖值，帮助他们管理药物和调整生活方式。同样，家庭胆固醇测试可以让有心血管疾病风险的人监测自己的健康状况并做出明智的生活方式改变。随着人口老化和慢性病的增加，OTC检测为定期健康监测提供了实用的解决方案，并支持早期发现和介入。这种可近性不仅改善了个人的健康结果，而且还减轻了医疗机构的负担，因为日常监测所需的资源更少。

此外，随着越来越多的人寻求健康管理方法以应对健康意识的提高，非处方药检测也越来越受到关注。从针对计划生育的夫妇的不孕不育测试，到了解家庭血统和倾向的基因检测套组，OTC 测试正在满足个性化预防性医疗保健的需求。随着检测技术的快速进步，可靠且易于使用的 OTC 检测数量不断增加，以满足各种需求并让个人了解自己的健康状况。 OTC 测试透过向公众提供诊断测试来弥合个人与及时医疗保健之间的差距，从而实现早期疗育和主动健康管理。

技术进步如何加强 OTC 测试市场？

技术进步正在帮助 OTC 检测市场不断发展和壮大，使检测更加准确、价格实惠且更易于使用。生化和分子生物学测试的创新显着提高了 OTC 测试的灵敏度和特异性，为使用者提供了与实验室测试相当的可靠结果。例如，侧向层析和免疫测量技术的进步增强了对怀孕、感染疾病、药物使用等的快速检测。这些测试现在可以在几分钟内提供结果，为个人提供快速方便的健康见解。数位技术的集成，例如支援蓝牙的血糖仪和智慧型手机应用程序，允许用户追踪、储存和分析他们的健康资料，以帮助做出明智的决策并在需要时改善健康管理，帮助与护理提供者共用结果。

家庭基因检测是另一个受益于技术进步的领域，使得分析唾液样本中的 DNA 成为可能。曾经价格昂贵且只能在专业实验室获得的 DNA检测套组现在可以透过 OTC 管道获得，让用户能够深入了解自己的血统、健康风险和遗传倾向。这些检测套组使用先进的基因组分析演算法和实验室处理来解释复杂的遗传资料并以消费者友好的格式呈现。随着人们对个人化健康资讯越来越感兴趣，OTC 基因检测提供了一种简单的方法来了解遗传健康风险，以指南生活方式选择和预防性护理。个人化医疗保健的兴起刺激了对这些测试的需求，并支持非处方药测试技术的进一步创新。

远端医疗和数位健康平台还透过创建连接家庭检测和医疗保健提供者的生态系统来推动 OTC 检测市场的成长。许多数位健康应用程式与 OTC 测试设备相容，允许用户远端咨询医疗保健专业人员并根据测试结果获得指导。 OTC 检测和远端医疗的这种集成为用户提供了在家检测和在线咨询医生的无缝体验，所有这些都在短时间内完成。例如，透过 COVID-19 家庭检测，您可以在舒适的家中接收检测结果，减少您的接触机会，并在需要时提供及时的医疗建议。随着远端医疗采用的扩大，家庭检测和虚拟护理的协同效应将增强非处方药检测的相关性，从而创造一种优先考虑可及性和便利性的全面医疗保健体验。

OTC 检测对消费者和医疗保健提供者有哪些好处？

OTC 测试为消费者和医疗保健提供者提供了显着的好处，并且是提高医疗保健可近性和效率的宝贵工具。 OTC 测试对消费者的主要好处是方便。由于您可以在家中进行测试，因此 OTC 测试消除了与传统实验室测试相关的日程安排、旅行和等待时间。这种便利性对于行动不便、居住在农村地区或日程繁忙而难以前往医疗机构的人们尤其有利。非处方测试（例如妊娠测试、血糖仪和快速抗原测试）可以为使用者提供即时结果，让使用者安心无忧。透过减少实验室访问，OTC检测使消费者能够掌控自己的健康并随时监测自己的健康状况，并支持主动的健康管理。

对于患有慢性病的人来说，非处方药检测提供了持续健康监测的重要好处。定期居家检测血糖值、胆固醇和血压可以让您预防併发症并及时进行医疗干预，从而更有效地管理您的健康状况。这种连续监测功能可以方便地追踪进展情况，无需频繁就诊，从而提高患者的依从性。非处方药检测还可以透过促进高胆固醇和血糖水平异常等疾病的早期检测来改善健康结果。例如，家庭大肠癌筛检测试可以及早发现并开始治疗，从而显着提高存活率。因此，非处方药检测在预防性医疗保健中发挥重要作用，帮助个人就其健康做出明智的决定。

对于医疗保健提供者而言，OTC 测试还具有减少对医疗设施的需求并允许提供者专注于危重病例的好处。透过让患者独立监测自己的健康状况，OTC 检测可以减少常规实验室就诊的次数，并为需要更强化治疗的患者腾出资源。这对于满足日益增长的医疗保健服务需求和最大限度地减少医疗保健系统的瓶颈特别有利。此外，从 OTC 测试收集的资料可以与医疗保健提供者共用，以便远端监控慢性病患者。治疗师可以使用这些资料来追踪患者的进展、调整治疗计划并在出现问题时迅速介入。 OTC 测试支援医疗保健协作方法，透过促进有效的病患监测来改善结果并减少医疗保健基础设施的压力。

是什么推动了 OTC 检测市场的成长？

健康意识的提高、对可及的医疗保健解决方案的需求、检测技术的进步以及慢性病患病率的增加等因素正在推动非处方药检测市场的成长。随着健康意识不断提高，越来越多的人正在寻找在家中监测健康状况的工具，从而推动了对非处方药检测的需求。当今的消费者对自己的健康非常积极主动，OTC 测试提供了一种便捷的方法来检查高血压、胆固醇和血糖水平等疾病，而无需经常去看医生。这种自我管理方法符合预防性医疗保健的成长趋势，即个人定期监测自己的健康状况，以便及早发现和解决潜在问题。

随着世界各地的医疗保健系统面临人口老化和管理有限资源的挑战，对可访问的医疗保健解决方案的需求也将极大地促进非处方药检测市场的成长。 OTC 检测提供了一种经济高效的解决方案，允许个人在家中接受定期检测，减轻医疗机构的负担，并让更多的人能够接受检测。在医疗保健机会有限的农村和服务欠缺地区，非处方药检测透过提供基本的诊断功能而无需前往医疗机构，从而填补了空白。随着医疗保健成本持续上升，非处方药检测提供了一种负担得起的替代方案，支持广泛获得医疗保健，特别是在医疗保健基础设施有限的地区。

测试准确性和易用性方面的技术进步也加速了 OTC 测试的采用。生物技术的创新提高了 OTC 测试的可靠性和特异性，使其高度准确且可与实验室测试相媲美。例如，快速诊断测试的进步使得在家中检测 COVID-19 和流感等感染疾病成为可能，从而为用户提供及时的资讯以告知自我隔离和医疗护理决策。此外，远端医疗的兴起进一步将非处方药测试整合到医疗保健中。远距会诊和数位健康平台使患者能够根据家庭测试结果获得医疗建议。 OTC 测试和远端医疗的无缝整合对于寻求便捷且高效的医疗保健解决方案的患者尤其有吸引力。

最后，糖尿病、心血管疾病和高血压等慢性病的盛行率不断上升，推动了对可定期监测的非处方药检测产品的需求。由于慢性疾病需要频繁的健康检查，OTC 测试提供了一种方便有效的解决方案，使患者能够持续监测自己的病情。管理这些慢性病的人通常使用血糖值监测仪、胆固醇测试和血压监测仪，使他们能够根据需要调整治疗计划。这种趋势可能会持续下去，因为慢性病仍然是一个主要的公共卫生问题，而非处方药检测为患者提供了一种主动管理健康的方法。这些因素的结合，包括健康意识的提高、对可近医疗保健的需求、技术进步和慢性病的流行，导致非处方药检测市场显着增长，使其成为现代医疗保健和预防医学的基石。

部分

测试类型（血糖监测测试、怀孕/不孕症测试、传染病检查、凝血监测测试、尿液检查、胆固醇测试、滥用药物测试、其他测试类型）、技术（横向流动化验、免疫测量、试纸）

调查企业举例（总合33家）

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP22445

Global Over The Counter (OTC) Testing Market to Reach US$43.6 Billion by 2030

The global market for Over The Counter (OTC) Testing estimated at US$23.3 Billion in the year 2023, is expected to reach US$43.6 Billion by 2030, growing at a CAGR of 9.3% over the analysis period 2023-2030. Glucose Monitoring Tests, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.7 Billion by the end of the analysis period. Growth in the Pregnancy & Fertility Tests segment is estimated at 9.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.3 Billion While China is Forecast to Grow at 8.8% CAGR

The Over The Counter (OTC) Testing market in the U.S. is estimated at US$6.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Global Over-the-Counter (OTC) Testing Market - Key Trends & Drivers Summarized

Why Is Over-the-Counter Testing Essential for Accessible Healthcare?

Over-the-counter (OTC) testing has revolutionized healthcare by providing individuals with direct access to health tests that can be conducted privately and conveniently at home. OTC tests enable users to monitor a range of health indicators, from blood glucose and cholesterol levels to pregnancy, fertility, and infectious diseases, without requiring a doctor’s visit or prescription. As healthcare shifts toward more patient-centered and accessible care, OTC testing has become an essential tool for individuals seeking to manage their health proactively. By allowing people to test at their convenience, OTC tests eliminate barriers associated with traditional lab-based testing, such as time, cost, and accessibility issues, making healthcare more inclusive.

OTC testing has been particularly impactful for managing chronic conditions like diabetes, where continuous monitoring is crucial for effective care. Blood glucose meters, one of the most widely used OTC tests, empower diabetic patients to track their sugar levels daily, aiding in medication management and lifestyle adjustments. Similarly, at-home cholesterol tests allow individuals at risk of cardiovascular disease to monitor their health and make informed lifestyle changes. With an aging population and increasing rates of chronic illnesses, OTC testing provides a practical solution for regular health monitoring, supporting early detection and intervention. This accessibility not only improves individual health outcomes but also reduces the burden on healthcare facilities, as fewer resources are required for routine monitoring.

Additionally, OTC testing has gained traction in response to rising health awareness, as more people seek ways to take control of their wellness. From fertility tests for couples planning a family to genetic testing kits for understanding ancestry and predispositions, OTC testing meets the demand for personalized, preventive healthcare. With rapid advances in testing technology, a growing range of reliable, user-friendly OTC tests is now available, catering to diverse needs and empowering individuals to stay informed about their health. By making diagnostic testing accessible to the general public, OTC testing bridges the gap between individuals and timely healthcare, enabling early interventions and proactive health management.

How Are Technological Advancements Enhancing the OTC Testing Market?

Technological advancements have been instrumental in the growth and evolution of the OTC testing market, making tests more accurate, affordable, and user-friendly. Innovations in biochemical and molecular testing have significantly improved the sensitivity and specificity of OTC tests, providing users with reliable results that are comparable to lab-based testing. For example, advancements in lateral flow and immunoassay technologies have enhanced rapid testing for conditions like pregnancy, infectious diseases, and drug use. These tests now produce results within minutes, offering individuals fast, convenient health insights. Digital technology integration, such as Bluetooth-enabled blood glucose meters and smartphone apps, allows users to track, store, and analyze their health data, helping them make informed decisions and share results with healthcare providers as needed.

At-home genetic testing is another area that has benefited from technological advancements, making it possible to analyze DNA from a simple saliva sample. DNA testing kits, which were once expensive and only available through specialized labs, are now accessible through OTC channels and provide users with insights into their ancestry, health risks, and genetic predispositions. These kits use advanced genomic analysis algorithms and lab processing to interpret complex genetic data, presenting it in an accessible format for consumers. As people become more interested in personalized health information, OTC genetic testing offers an easy way to understand genetic health risks, which can guide lifestyle choices and preventive care. The rise of personalized healthcare has fueled demand for these tests, supporting further innovation in OTC testing technology.

Telemedicine and digital health platforms have also driven growth in the OTC testing market by creating an ecosystem that connects at-home testing with healthcare providers. Digital health apps, many of which are compatible with OTC testing devices, allow users to consult healthcare professionals remotely and receive guidance based on their test results. This integration of OTC testing with telemedicine provides a seamless experience, where users can test at home and consult a doctor online, all within a short timeframe. For example, COVID-19 home tests allow individuals to receive test results without leaving their home, reducing exposure and facilitating timely medical advice if needed. As telemedicine adoption expands, the synergy between at-home testing and virtual care strengthens the relevance of OTC tests, creating a holistic healthcare experience that prioritizes accessibility and convenience.

What Are the Benefits of OTC Testing for Consumers and Healthcare Providers?

OTC testing provides substantial benefits for both consumers and healthcare providers, making it a valuable tool in enhancing healthcare accessibility and efficiency. For consumers, the main advantage of OTC testing is convenience. By enabling people to test at home, OTC testing eliminates the need for scheduling, travel, and waiting times associated with traditional lab tests. This convenience is especially beneficial for individuals with mobility issues, those living in rural areas, or people with busy schedules who find it challenging to visit a healthcare facility. OTC tests, such as pregnancy tests, blood glucose meters, and rapid antigen tests, offer users immediate results and peace of mind. By reducing the dependency on lab visits, OTC testing empowers consumers to take control of their health and monitor their well-being at any time, supporting proactive health management.

For individuals with chronic conditions, OTC testing offers the critical benefit of continuous health monitoring. Regular at-home testing for blood glucose, cholesterol, or blood pressure enables individuals to manage their conditions more effectively, preventing complications and allowing for timely medical interventions. This continuous monitoring capability improves patient compliance, as users can conveniently track their progress without frequent clinic visits. OTC tests also enhance health outcomes by promoting early detection of conditions like high cholesterol or abnormal glucose levels, allowing individuals to make lifestyle changes or seek medical advice before conditions worsen. For example, at-home colon cancer screening tests allow for early detection, significantly improving survival rates when treatment begins early. OTC testing thus plays a crucial role in preventive care, supporting individuals in making informed decisions about their health.

Healthcare providers also benefit from OTC testing, as it helps alleviate the demand on healthcare facilities and enables providers to focus on critical cases. By empowering patients to monitor their health independently, OTC testing reduces the number of routine lab visits, freeing up resources for patients who require more intensive care. This is particularly beneficial in managing the rising demand for healthcare services and minimizing bottlenecks in the healthcare system. Additionally, data collected from OTC testing can be shared with healthcare providers, allowing for remote monitoring of patients with chronic conditions. Providers can use this data to track patient progress, make adjustments to treatment plans, and intervene promptly if issues arise. By facilitating efficient patient monitoring, OTC testing supports a collaborative approach to healthcare that enhances outcomes and reduces the burden on healthcare infrastructure.

What Is Fueling the Growth in the OTC Testing Market?

The growth in the OTC testing market is driven by factors such as rising health awareness, the need for accessible healthcare solutions, advancements in testing technology, and the increasing prevalence of chronic conditions. As health awareness continues to rise, more people are seeking tools that allow them to monitor their health from home, leading to a greater demand for OTC tests. Consumers today are more proactive in managing their health, and OTC testing offers a convenient way to check for conditions like high blood pressure, cholesterol, and glucose levels without the need for frequent doctor visits. This self-management approach aligns with the growing trend of preventive healthcare, where individuals monitor their health regularly to detect and address potential issues early.

The need for accessible healthcare solutions has also contributed significantly to the growth of the OTC testing market, as healthcare systems worldwide face challenges in meeting the demands of an aging population and managing limited resources. OTC testing provides a cost-effective solution by enabling individuals to take routine tests at home, reducing the burden on healthcare facilities and making testing accessible to a wider population. In rural or underserved areas where healthcare access is limited, OTC testing bridges the gap by providing essential diagnostic capabilities without requiring travel to a medical facility. As healthcare costs continue to rise, OTC testing offers an affordable alternative that supports broader access to healthcare, especially in regions with limited medical infrastructure.

Technological advancements in testing accuracy and ease of use have also accelerated the adoption of OTC testing. Innovations in biotechnology have improved the reliability and specificity of OTC tests, making them highly accurate and comparable to lab-based tests. For instance, advancements in rapid diagnostic tests have made it possible to detect infectious diseases like COVID-19 and influenza at home, providing users with timely information that can guide decisions on self-isolation and medical care. Additionally, the rise of telehealth has further integrated OTC testing into healthcare, as remote consultations and digital health platforms allow patients to receive medical advice based on their at-home test results. This seamless integration of OTC testing and telemedicine is especially appealing to patients seeking accessible and efficient healthcare solutions.

Finally, the increasing prevalence of chronic conditions, such as diabetes, cardiovascular disease, and high blood pressure, has fueled demand for OTC testing products that allow for regular monitoring. As chronic diseases require frequent health checks, OTC testing offers a convenient, effective solution for patients to monitor their condition consistently. Blood glucose monitors, cholesterol tests, and blood pressure cuffs are commonly used by individuals managing these chronic conditions, enabling them to adjust their treatment plans as needed. This trend is likely to continue as chronic conditions remain a significant public health issue, with OTC testing providing patients with the tools to manage their health proactively. Together, these factors—rising health awareness, the need for accessible healthcare, technological advancements, and the prevalence of chronic conditions—are driving substantial growth in the OTC testing market, making it a cornerstone of modern healthcare and preventive medicine.

SCOPE OF STUDY:

The report analyzes the Over The Counter (OTC) Testing market in terms of US$ Million by the following Technology; Test Type, and Geographic Regions/Countries:

Segments:

Test Type (Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests, Other Test Types); Technology (Lateral Flow Assays, Immunoassays, Dipsticks)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Over The Counter (OTC) Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Home-Based Health Monitoring Drives OTC Testing Market
    • Increasing Awareness About Preventive Healthcare Sets the Stage for OTC Testing Adoption
    • Rising Adoption of Self-Testing Kits for Chronic Disease Management
    • Increasing Use of OTC Testing in Monitoring Infectious Diseases Propels Demand
    • Demand for Rapid and Accurate Results Spurs OTC Testing Solutions
    • OTC Testing as a Key Solution for Reducing Healthcare Costs
    • Use in Detecting Lifestyle Disorders Expands OTC Testing Adoption
    • Rising Demand for Genetic Testing Kits Sets the Stage for Market Growth
    • Increasing Use of OTC Testing in Monitoring Diabetes and Heart Conditions
    • Increasing Focus on Female Health Solutions Expands OTC Testing Opportunities
    • OTC Testing for Allergies and Food Intolerances Generates Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Glucose Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Pregnancy & Fertility Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Infectious Disease Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Coagulation Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Urinalysis Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Cholesterol Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Drugs-of-Abuse Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 36: World 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 37: World Over The Counter (OTC) Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • JAPAN
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • CHINA
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • EUROPE
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • FRANCE
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • GERMANY
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of World 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030

IV. COMPETITION